Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2009

01-02-2009 | Gastrointestinal Oncology

Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus

Authors: Ralf Metzger, MD, Uta Drebber, MD, Stephan E. Baldus, MD, Stefan P. Mönig, MD, Arnulf H. Hölscher, MD, Elfriede Bollschweiler, MD

Published in: Annals of Surgical Oncology | Issue 2/2009

Login to get access

Abstract

There is increasing evidence regarding extracapsular lymph node involvement (LNI) as a prognostic factor for recurrence and poor prognosis in gastrointestinal malignancies. The aim of this study was to assess the prevalence and prognostic impact of LNI in patients with resected esophageal cancer, comparing adenocarcinoma (AC) and squamous cell carcinoma (SCC). Between 1997 and 2006, 243 consecutive patients with resected esophageal cancer without neoadjuvant therapy (103 SCC, 140 AC) were studied. A total of 738 lymph node metastases were reexamined. Survival was analyzed according to intra- and extracapsular LNI. Median survival in patients with extracapsular LNI was 13 months [range 11–14 months, 95% confidence interval (CI)] compared with 28 months (21–34 months, 95% CI) for those with intracapsular LNI alone (p = 0.017). Node-positive patients with AC showed a prevalence of 66% extracapsular LNI compared with 35% in patients with SCC (p < 0.001). The number of resected lymph nodes and the frequency of pN1 cases were comparable between AC and SCC. However the number of infiltrated LN was significantly (p = 0.005) higher in patients with pN1 AC (median = 5) compared with pN1 SCC (median = 3). We conclude that extracapsular LNI is an independent negative prognostic factor which occurs more frequently in esophageal AC than SCC.
Literature
1.
go back to reference Lagarde S, ten Kate F, de Boer D, Busch O, Obertop H, van Lanschot J. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol. 2006;30:171–6.PubMedCrossRef Lagarde S, ten Kate F, de Boer D, Busch O, Obertop H, van Lanschot J. Extracapsular lymph node involvement in node-positive patients with adenocarcinoma of the distal esophagus or gastroesophageal junction. Am J Surg Pathol. 2006;30:171–6.PubMedCrossRef
2.
go back to reference Gu Y, Swisher S, Ajani J, Correa A, Hofstetter W, Liao Z, et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106:1017–25.PubMedCrossRef Gu Y, Swisher S, Ajani J, Correa A, Hofstetter W, Liao Z, et al. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006;106:1017–25.PubMedCrossRef
3.
go back to reference Cense H, van Eijck CH, Tilanus H. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893–906.PubMedCrossRef Cense H, van Eijck CH, Tilanus H. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection. Best Pract Res Clin Gastroenterol. 2006;20:893–906.PubMedCrossRef
4.
go back to reference Bollschweiler E, Baldus S, Schroder W, Schneider P, Holscher A. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94:355–63.PubMedCrossRef Bollschweiler E, Baldus S, Schroder W, Schneider P, Holscher A. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94:355–63.PubMedCrossRef
5.
go back to reference Omloo J, Lagarde S, Hulscher J, Reitsma J, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1000; discussion 1000–1.PubMed Omloo J, Lagarde S, Hulscher J, Reitsma J, Fockens P, van Dekken H, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246:992–1000; discussion 1000–1.PubMed
6.
go back to reference Barbour A, Rizk N, Gonen M, Tang L, Bains M, Rusch V, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14:306–16.PubMedCrossRef Barbour A, Rizk N, Gonen M, Tang L, Bains M, Rusch V, et al. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol. 2007;14:306–16.PubMedCrossRef
7.
go back to reference Wind J, ten Kate F, Kiewiet J, Lagarde S, Slors J, van Lanschot J, et al. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol. 2008;34:390–6.PubMed Wind J, ten Kate F, Kiewiet J, Lagarde S, Slors J, van Lanschot J, et al. The prognostic significance of extracapsular lymph node involvement in node positive patients with colonic cancer. Eur J Surg Oncol. 2008;34:390–6.PubMed
8.
go back to reference Gorgulu S, Can M, Yagci G, Sahin M, Tufan T. Extracapsular extension is associated with increased ratio of metastatic to examined lymph nodes in axillary node-positive breast cancer. Clin Breast Cancer. 2007;7:796–800.PubMedCrossRef Gorgulu S, Can M, Yagci G, Sahin M, Tufan T. Extracapsular extension is associated with increased ratio of metastatic to examined lymph nodes in axillary node-positive breast cancer. Clin Breast Cancer. 2007;7:796–800.PubMedCrossRef
9.
go back to reference Oosterkamp S, de Jong J, van den Ende P, Manni J, Dehing-Oberije C, Kremer B. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. Laryngoscope. 2006;116:2067–70.PubMedCrossRef Oosterkamp S, de Jong J, van den Ende P, Manni J, Dehing-Oberije C, Kremer B. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. Laryngoscope. 2006;116:2067–70.PubMedCrossRef
10.
go back to reference Nakamura K, Ozaki N, Yamada T, Hata T, Sugimoto S, Hikino H, et al. Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Surgery. 2005;137:511–7.PubMedCrossRef Nakamura K, Ozaki N, Yamada T, Hata T, Sugimoto S, Hikino H, et al. Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Surgery. 2005;137:511–7.PubMedCrossRef
11.
go back to reference Wind J, Lagarde S, Ten Kate F, Ubbink D, Bemelman W, van Lanschot J. A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies. Eur J Surg Oncol. 2007;33:401–8.PubMedCrossRef Wind J, Lagarde S, Ten Kate F, Ubbink D, Bemelman W, van Lanschot J. A systematic review on the significance of extracapsular lymph node involvement in gastrointestinal malignancies. Eur J Surg Oncol. 2007;33:401–8.PubMedCrossRef
12.
go back to reference Stitzenberg K, Meyer A, Stern S, Cance W, Calvo B, Klauber-De MN, et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg. 2003;237:607–12; discussion 612–3.PubMedCrossRef Stitzenberg K, Meyer A, Stern S, Cance W, Calvo B, Klauber-De MN, et al. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden. Ann Surg. 2003;237:607–12; discussion 612–3.PubMedCrossRef
13.
go back to reference Lyons A, Bateman A, Spedding A, Primrose J, Mandel U. Oncofetal fibronectin and oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2001;39:471–7.PubMedCrossRef Lyons A, Bateman A, Spedding A, Primrose J, Mandel U. Oncofetal fibronectin and oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2001;39:471–7.PubMedCrossRef
14.
go back to reference Sobin L, Wittekind C. UICC (2002) TNM classification of malignant tumors. 6th ed. Wiley, 2002. Sobin L, Wittekind C. UICC (2002) TNM classification of malignant tumors. 6th ed. Wiley, 2002.
15.
go back to reference Schneider P, Baldus S, Metzger R, Kocher M, Bongartz R, Bollschweiler E, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684–92.PubMedCrossRef Schneider P, Baldus S, Metzger R, Kocher M, Bongartz R, Bollschweiler E, et al. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification. Ann Surg. 2005;242:684–92.PubMedCrossRef
16.
go back to reference Schroder W, Bollschweiler E, Kossow C, Holscher A. Preoperative risk analysis-a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg. 2006;391:455–60.PubMedCrossRef Schroder W, Bollschweiler E, Kossow C, Holscher A. Preoperative risk analysis-a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg. 2006;391:455–60.PubMedCrossRef
17.
go back to reference Hölscher A, Schroder W, Bollschweiler E, Beckurts K, Schneider P. How safe is high intrathoracic esophagogastrostomy? Chirurg. 2003;74:726–33.PubMedCrossRef Hölscher A, Schroder W, Bollschweiler E, Beckurts K, Schneider P. How safe is high intrathoracic esophagogastrostomy? Chirurg. 2003;74:726–33.PubMedCrossRef
18.
go back to reference Wijnhoven B, Tran K, Esterman A, Watson D, Tilanus H. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245:717–25.PubMedCrossRef Wijnhoven B, Tran K, Esterman A, Watson D, Tilanus H. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007;245:717–25.PubMedCrossRef
19.
go back to reference Mariette C, Piessen G, Briez N, Triboulet J. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247:365–71.PubMedCrossRef Mariette C, Piessen G, Briez N, Triboulet J. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent. Ann Surg. 2008;247:365–71.PubMedCrossRef
20.
go back to reference Bollschweiler E. Benefits and limitations of Kaplan–Meier calculations of survival chance in cancer surgery. Langenbecks Arch Surg. 2003;388:239–44.PubMedCrossRef Bollschweiler E. Benefits and limitations of Kaplan–Meier calculations of survival chance in cancer surgery. Langenbecks Arch Surg. 2003;388:239–44.PubMedCrossRef
21.
go back to reference Lerut T, Moons J, Fieuws S. Extracapsular lymph node involvement in esophageal cancer and number of involved nodes. J Thorac Cardiovasc Surg. 2004;127:1855–6.PubMedCrossRef Lerut T, Moons J, Fieuws S. Extracapsular lymph node involvement in esophageal cancer and number of involved nodes. J Thorac Cardiovasc Surg. 2004;127:1855–6.PubMedCrossRef
22.
go back to reference Tachikawa D, Inada S, Kotoh T, Futami K, Arima S, Iwashita A. An evaluation of malignancy and prognostic factors based on mode of lymph node metastasis in esophageal carcinoma. Surg Today. 1999;29:1131–5.PubMedCrossRef Tachikawa D, Inada S, Kotoh T, Futami K, Arima S, Iwashita A. An evaluation of malignancy and prognostic factors based on mode of lymph node metastasis in esophageal carcinoma. Surg Today. 1999;29:1131–5.PubMedCrossRef
23.
go back to reference Nakano S, Baba M, Shimada M, Shirao K, Noguchi Y, Kusano C, et al. How the lymph node metastases toward cervico-upper mediastinal region affect the outcome of patients with carcinoma of the thoracic esophagus. Jpn J Clin Oncol. 1999;29:248–51.PubMedCrossRef Nakano S, Baba M, Shimada M, Shirao K, Noguchi Y, Kusano C, et al. How the lymph node metastases toward cervico-upper mediastinal region affect the outcome of patients with carcinoma of the thoracic esophagus. Jpn J Clin Oncol. 1999;29:248–51.PubMedCrossRef
Metadata
Title
Extracapsular Lymph Node Involvement Differs Between Squamous Cell and Adenocarcinoma of the Esophagus
Authors
Ralf Metzger, MD
Uta Drebber, MD
Stephan E. Baldus, MD
Stefan P. Mönig, MD
Arnulf H. Hölscher, MD
Elfriede Bollschweiler, MD
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2009
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-008-0248-9

Other articles of this Issue 2/2009

Annals of Surgical Oncology 2/2009 Go to the issue